Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor

被引:69
|
作者
Tavakkol, A
Varani, J
Elder, JT
Zouboulis, CC [1 ]
机构
[1] Free Univ Berlin, Dept Dermatol, Med Ctr Benjamin Franklin, D-12200 Berlin, Germany
[2] Colgate Palmolive Co, Skin Clin Invest Grp, Piscataway, NJ USA
[3] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA
[4] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA
关键词
insulin-like growth factor-1; insulin-like growth factor-1 receptor; epidermal growth factor; epidermal growth factor receptor; epidermis;
D O I
10.1007/s004030050469
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Recent studies have shown that adult skin incubated in low-Ca2+ (0.15 mM) medium rapidly degenerates but that normal architecture is maintained when the tissue is incubated in high-Ca2+ medium (1.4 mM Ca2+). To investigate whether the skin cell-produced growth factors insulin-like growth factor-1 (IGF-1) and epidermal growth factor (EGF) play a role in these events, 2-mm skin punch biopsies were obtained and maintained for 8 to 10 days in a basal medium containing 0.15 mM Ca2+ with and without growth factors, or containing 1.4 mM Ca2+ with and without antibodies to the same growth factors. In parallel experiments, cultured human keratinocytes were incubated for 2 days in the same basal medium in the presence or absence of the same growth factors and antibodies. Consistent with previous reports, organ cultures incubated in the low-Ca2+ (0.15 mM) medium rapidly degenerated. Neither IGF-1 nor EGF prevented the complete degeneration of epidermis and dermis in these organ cultures. Interestingly, the addition of an anti-IGF-1 receptor (IGP-1R) antibody to the organ cultures maintained in high-Ca2+ medium induced changes reminiscent of those seen when the organ cultures were maintained in low-Ca2+ medium, i.e. tissue degeneration. In contrast, antibodies to EGF receptor, used for comparison, only produced focal areas of epidermal necrosis. In vitro, IGF-1 is a known mitogen for keratinocytes. In cultured human keratinocytes, anti-IGF-1R antibody partially inhibited the IGF-1-mediated stimulation of human keratinocyte proliferation without affecting normal spontaneous growth. Additionally, IGF-1R immunolocalized to basal keratinocytes in vivo, exhibited specific binding to IGF-1 in vitro. This indicated a critical role for IGF-1R in both organ cultures ex vivo and cultured cells in vitro. Messenger RNA encoding both IGF-1 and IGF-1R were readily detected by RT-PCR in organ cultures incubated in both low- and high-Ca2+ medium. There were no detectable differences in IGF-1 mRNA in organ cultures growing in the low- or high-Ca2+ medium, but lower levels of IGF-1R mRNA were observed in the organ cultures maintained in low-Ca2+ medium than in those in high Ca(2+)medium. These findings are consistent with homeostatic changes in the tissue grown under different calcium concentrations. IGF-1 mRNA was detected in several skin cell populations in vitro, even though it was undetectable in cultured keratinocytes. Taken together these findings indicate that (1) the IGF-1/IGF-1R loop is critically involved in maintenance of human skin organ cultures ex vivo, and (2) IGF-1, locally produced by skin cells other than keratinocytes, interacts with its receptor, predominantly expressed in basal keratinocytes, to maintain tissue homeostasis.
引用
收藏
页码:643 / 651
页数:9
相关论文
共 50 条
  • [1] Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor
    A. Tavakkol
    J. Varani
    J. T. Elder
    Ch. C. Zouboulis
    Archives of Dermatological Research, 1999, 291 : 643 - 651
  • [2] Targeting the insulin-like growth factor-1 receptor in human cancer
    Arcaro, Alexandre
    FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [3] Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma
    Desbois-Mouthon, Christele
    Baron, Aurore
    Blivet-Van Eggelpoel, Marie-Jose
    Fartoux, Laetitia
    Venot, Corinne
    Bladt, Friedhelm
    Housset, Chantal
    Rosmorduc, Olivier
    CLINICAL CANCER RESEARCH, 2009, 15 (17) : 5445 - 5456
  • [4] Signalling by the type 1 insulin-like growth factor receptor: Interplay with the epidermal growth factor receptor
    Adams, TE
    McKern, NM
    Ward, CW
    GROWTH FACTORS, 2004, 22 (02) : 89 - 95
  • [5] Relationships of Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor Expression to Clinical Outcomes in Patients with Colorectal Cancer
    Takahari, Daisuke
    Yamada, Yasuhide
    Okita, Natuko T.
    Honda, Takuya
    Hirashima, Yoshinori
    Matsubara, Junichi
    Takashima, Atsuo
    Kato, Ken
    Hamaguchi, Tetsuya
    Shirao, Kuniaki
    Shimada, Yasuhiro
    Shimoda, Tadakazu
    ONCOLOGY, 2009, 76 (01) : 42 - 48
  • [6] Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
    van der Veeken, J.
    Oliveira, S.
    Schiffelers, R. M.
    Storm, G.
    Henegouwen, P. M. P. van Bergen En
    Roovers, R. C.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (06) : 748 - 760
  • [7] Relationship of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer
    Takahari, D.
    Yamada, Y.
    Okita, N.
    Hirashima, Y.
    Matsubara, J.
    Takashima, A.
    Kato, K.
    Hamaguchi, T.
    Shirao, K.
    Shimada, Y.
    Shimoda, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor
    Burgaud, JL
    Baserga, R
    EXPERIMENTAL CELL RESEARCH, 1996, 223 (02) : 412 - 419
  • [9] The complex biology of the receptor for the insulin-like growth factor-1
    Romano, G
    DRUG NEWS & PERSPECTIVES, 2003, 16 (08) : 525 - 531
  • [10] Glycan Modulation of Insulin-like Growth Factor-1 Receptor
    Boothello, Rio S.
    Sankaranarayanan, Nehru Viji
    Sistla, Jyothi C.
    Nagarajan, Balaji
    Sharon, Chetna
    Chittum, John E.
    Niyaz, Rabiya Y.
    Roy, Swarnali
    Nandi, Aditi
    O'Hara, Connor P.
    Gangji, Rahaman Navaz
    Afosah, Daniel K.
    Ongolu, Ravikumar
    Patel, Bhaumik B.
    Desai, Umesh R.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 61 (49)